Clinical Trial Details
| Trial ID: | L5231 |
| Source ID: | NCT04375943 |
| Associated Drug: | Antidiabetic |
| Title: | Clinical and Echocardiographic Management of Patients With Heart Failure and Diabetes: SCODIAC Follow up Study |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes|Heart Failure |
| Interventions: | DRUG: Antidiabetic |
| Outcome Measures: | Primary: Total Cholesterol, LDL, HDL Triglycerides, Creatinine, mg/dl, 12 months|B-type natriuretic peptide (BNP), pmol/m, 12 months|HbA1c, mmol/L, 12 months|Ejection Fraction, 12 months|Left Ventricular End-Diastolic Volume Index (LV-EDVi), Left Ventricular End-Systolic Volume Index (LV-ESVi), Left Atrial Volume Index (LAVi), ml/m2, 12 months|E velocity, A velocity,E' velocity, m/sec, 12 months | |
| Sponsor/Collaborators: | Sponsor: Federico II University |
| Gender: | ALL |
| Age: | OLDER_ADULT |
| Phases: | |
| Enrollment: | 406 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2018-04-01 |
| Completion Date: | 2019-09-01 |
| Results First Posted: | |
| Last Update Posted: | 2020-05-06 |
| Locations: | Federico II University, Naples, 80131, Italy |
| URL: | https://clinicaltrials.gov/show/NCT04375943 |
